SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001114220-18-000106
Filing Date
2018-11-13
Accepted
2018-11-09 17:39:20
Documents
5
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A keryx-10xq_aq32018xcoverpa.htm 10-Q/A 31449
2 EXHIBIT 31.1 exhibit311q3201810qa.htm EX-31.1 1707
3 EXHIBIT 31.2 exhibit312q3201810qa.htm EX-31.2 1701
4 exhibit311q3201810qa001.jpg GRAPHIC 52851
5 exhibit312q3201810qa001.jpg GRAPHIC 52845
  Complete submission text file 0001114220-18-000106.txt   181603
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-30929 | Film No.: 181174257
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1